for hers compounded semaglutide Wegovy maker ends partnership with Hims & FDA Blocks Hims & Hers

Most adverse effects are dose-dependent, meaning they tend to be less severe at lower doses

The service will offer GLP-1 medication for those who qualify after receiving a prescription from one of its licensed medical providers

This is not a rule, just a pattern observed across thousands of trial participants

Quick Answer: Semaglutide does not directly cause frequent urination and is not listed as a common side effect in FDA prescribing information

The compound remains in clinical development rather than FDA approved, positioning it within research peptide markets rather than pharmaceutical distribution channels